EPIgeneous Binding Domain kit B HTRF®
- High sensitivity
- Good DMSO tolerance
The EPIgeneous Binding Domain kit series provides a simple biochemical approach to study epigenetic reader domain interactions with modified histones. All kits are based on a GST-tagged binding domain / biotin-coupled Histone peptide format, and can be run using the same add-and-read single plate protocol.
Binding Domain kit B has been successfully validated on a wide variety of readers (18), including some important therapeutic epigenetic targets.
- GOOD DMSO TOLERANCE
- HIGH SENSITIVITY
- LOW PROTEIN OR PEPTIDE CONSUMPTION
The validation of the EPIgeneous binding Domain B assay was performed using the Tudor Domain UHRF1 binding to [Lys(9)Me3] H3(1-21) peptide. The GST-UHRF1 concentration was fixed at 5 nM while the peptide-biotin was serially diluted.
The HTRF signal was proportional to the specific interaction measured between GST-UHRF1 and peptide-biotin.
The 2nM Kd value was determined from this experiment using a two-site specific binding regression. A slight shift of apparent Kd is observed when DMSO% increases.
Robust assay tools to decipher key epigenetic interactions - Flyers
Case study: BRD4 bromodomain - Posters
Get the brochure about technology comparison. - Brochures
Plate Reader Requirement
Choosing the right microplate reader ensures you’ll get an optimal readout. Discover our high performance reader, or verify if your lab equipment is going to be compatible with this detection technology.Let's find your reader